286 related articles for article (PubMed ID: 31808923)
21. Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.
Zhang R; Pang B; Xin T; Guo H; Xing Y; Xu S; Feng B; Liu B; Pang Q
Mol Neurobiol; 2016 Apr; 53(3):1452-1460. PubMed ID: 25636684
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.
Cerqua R; Balestrini S; Perozzi C; Cameriere V; Renzi S; Lagalla G; Mancini G; Montanari M; Leoni P; Scerrati M; Iacoangeli M; Silvestrini M; Luzzi S; Provinciali L
Neurol Sci; 2016 Jan; 37(1):23-29. PubMed ID: 26233232
[TBL] [Abstract][Full Text] [Related]
23. LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
Ge L; Xu L; Lu S; Yan H
FEBS Open Bio; 2020 May; 10(5):904-911. PubMed ID: 32237064
[TBL] [Abstract][Full Text] [Related]
24. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
Baraniskin A; Kuhnhenn J; Schlegel U; Chan A; Deckert M; Gold R; Maghnouj A; Zöllner H; Reinacher-Schick A; Schmiegel W; Hahn SA; Schroers R
Blood; 2011 Mar; 117(11):3140-6. PubMed ID: 21200023
[TBL] [Abstract][Full Text] [Related]
25. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.
Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
Clin Radiol; 2015 Dec; 70(12):1393-9. PubMed ID: 26382744
[TBL] [Abstract][Full Text] [Related]
26. Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks.
McAvoy M; Prieto PC; Kaczmarzyk JR; Fernández IS; McNulty J; Smith T; Yu KH; Gormley WB; Arnaout O
Sci Rep; 2021 Jul; 11(1):15219. PubMed ID: 34312463
[TBL] [Abstract][Full Text] [Related]
27. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
[TBL] [Abstract][Full Text] [Related]
28. A novel combination of serum microRNAs for the detection of early gastric cancer.
Abe S; Matsuzaki J; Sudo K; Oda I; Katai H; Kato K; Takizawa S; Sakamoto H; Takeshita F; Niida S; Saito Y; Ochiya T
Gastric Cancer; 2021 Jul; 24(4):835-843. PubMed ID: 33743111
[TBL] [Abstract][Full Text] [Related]
29. A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.
Sromek M; Rymkiewicz G; Paziewska A; Szafron LM; Kulecka M; Zajdel M; Kulinczak M; Dabrowska M; Balabas A; Bystydzienski Z; Chechlinska M; Siwicki JK
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572608
[TBL] [Abstract][Full Text] [Related]
30. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
[TBL] [Abstract][Full Text] [Related]
31.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
32. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
33. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
Wei X; Chen D; Lv T; Li G; Qu S
Mol Neurobiol; 2016 Jan; 53(1):163-170. PubMed ID: 25416859
[TBL] [Abstract][Full Text] [Related]
34. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
Malikova H; Koubska E; Weichet J; Klener J; Rulseh A; Liscak R; Vojtech Z
Cancer Imaging; 2016 Nov; 16(1):40. PubMed ID: 27894359
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of Enhancing Glioma and Primary Central Nervous System Lymphoma by Texture-Based Machine Learning.
Alcaide-Leon P; Dufort P; Geraldo AF; Alshafai L; Maralani PJ; Spears J; Bharatha A
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1145-1150. PubMed ID: 28450433
[TBL] [Abstract][Full Text] [Related]
36. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.
Baraniskin A; Zaslavska E; Nöpel-Dünnebacke S; Ahle G; Seidel S; Schlegel U; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2016 Mar; 18(3):361-7. PubMed ID: 26250566
[TBL] [Abstract][Full Text] [Related]
37. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
Chen J; Yang L; Wang X
Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
[TBL] [Abstract][Full Text] [Related]
38. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
[TBL] [Abstract][Full Text] [Related]
39. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
40. Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls.
Cordone I; Masi S; Carosi M; Vidiri A; Marchesi F; Marino M; Telera S; Pasquale A; Mengarelli A; Conti L; Pescarmona E; Pace A; Carapella CM
J Exp Clin Cancer Res; 2016 Aug; 35(1):128. PubMed ID: 27567676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]